CLEANICALL, in consultation
with the Therapeutic Goods
Administration, is recalling Maxagra
capsules aftter they were found to
contain the undeclared substances
sildenafil and oxytetracycline
according to a safety advisory
issued early last month (PD 04 Feb).
The capsules were being marketed
as a herbal medicine used to treat
erectile dysfunction.
Consumers with any unused
Maxagra capsules are advised to
contact Cleanicall on 03 9018 7768.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Mar 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Mar 16
MEDICATION management platform MedAdvisor Limited (MDR) showed strong financial performance for the quarter concluded on 31 Mar 2024, with operating revenue up 42% to $24.2 million from $17 million for the same period last year.
PHARMACIES in regional areas need a restructure of the 8CPA Community Service Obligation (CSO) to help fund them to support their workforce and deliver services, says the Remote and Isolated Pharmacist Association Australia (RIPAA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.